News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD
Mydecine Innovations Group
MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President
Mind Medicine (MindMed)
Tryp Therapeutics Partners with Albany Molecular Research Inc. to Manufacture a Proprietary Psilocybin-based Drug
Tryp Therapeutics
New Psychedelic Research Nonprofit Teams with Johns Hopkins University for Real-World Study on Use of Psilocybin Mushrooms
Unlimited Sciences
Lorne Gertner | Chairman, CannaGlobal Wellness
GoodCap Wellness
Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector
Mydecine Innovations Group
James Kuo, MD, MBA | Director, Tryp Therapeutics
Tryp Therapeutics
Cybin Applauds TheraPsil’s Advocacy to Bring Psilocybin Therapy to Palliative Care of Canadian Patients
Cybin Inc.
TheraPsil
NeonMind Submits Application for Psilocybin Research to Health Canada
NeonMind Biosciences Inc.
MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy
Mind Medicine (MindMed)
Red Light Holland Commences Magic Truffles Growth Operation in the Netherlands, Months Ahead of Schedule
Red Light Holland
Mindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness
Mydecine Innovations Group
Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada
Novamind Inc.
Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.
Novamind Inc.
Journal of Psychedelic Studies
No items found.
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.